The Discounted Cash Flow (DCF) valuation of Crinetics Pharmaceuticals Inc (CRNX) is (111.71) USD. With the latest stock price at 43.28 USD, the upside of Crinetics Pharmaceuticals Inc based on DCF is -358.1%.
Based on the latest price of 43.28 USD and our DCF valuation, Crinetics Pharmaceuticals Inc (CRNX) is a sell. selling CRNX stocks now will result in a potential gain of 358.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.5% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (619.71) - (63.27) | (111.71) |
| Upside | -1531.9% - -246.2% | -358.1% |